In addition, the combination treatment reduced the expression level of Ki67 (Fig. 8F, G) and upregulated that of cleaved caspase 3 (Fig. 8H, J) compared to the monotherapy groups in the ESCC PDX tumor tissues. The gene discussed is CASP3; the disease is neoplasm.